background: patients which have diagnosed with a cancer, have a life time risk for developing another de novo malignancy depending on various inherited, environmental and iatrogenic risk factors. cancer victims could survive longer due to settling treatment modalities, and then would likely develop a new metachronous malignancy. this article aims to report our observed trend of increasing, in p...

in this study we surveyed the average survival time of the treated hodgkin's lymphoma patients and also the side effects and malignancies occurring secondary to the treatment. this is a retrospective study of patients referring to ahwaz's shafa hospital in a period of 10 years diagnosed with hodgkin's lymphoma without any age restriction. after gathering all their data, we calculated their surv...

The development of a second malignancy, in the same patient, with a different histologic type and/or morphological site is an increasingly appreciated phenomenon in cancer patients. Factors incriminated for this development include genetic makeup of an individual, cytotoxic chemotberapeutic intervention for the first malignancy, radiation therapy, endocrine therapy and immunotherapy. Second mal...

Among 232 cases of operable breast cancer treated by the 2nd Department of Surgery, Hiroshima University School of Medicine, between 1963 and 1982, 7 cases (3. 0%) were followed by a second primary malignancy. Eighty six percent of the second primary malignancies were found in digestive systems. The incidence of a second primary malignancy was 6. 1%* (5/82) in the irradiated group and 1. 3%* (2...

Malignancy is one of the most frequent cause of death in children -in U.S. it is the second common cause (second to Tranma). Between childhood malignancy leukemia is by far the mO'st frequent one and C.N.S. tumors take the second place -abdominal tumor re­main the third common cause of children's malignancy -Retroperitoneal space with organs like, kidney, adrenal gland, sympatheti nervous syste...

Retinoblastoma patients have a strongly increased risk of second malignancies, and survivors with a third or subsequent malignancy are increasingly observed. However, it has not been examined whether survivors who developed a second malignancy have a greater risk of a subsequent malignancy. On the basis of the Dutch retinoblastoma registry, the risk of a third malignancy was compared with cance...